FDA Approved: VECTIBIX — Supplemental Application (Amgen, Inc)

View source ↗

Summary

The FDA approved a supplemental application for VECTIBIX (panitumumab) submitted by Amgen, expanding its regulatory status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Vectibix (panitumumab)

Snippet

SUPPL AP for VECTIBIX (PANITUMUMAB)